Guggenheim analyst, Louise Chen, reiterated her Buy rating on The Medicines Company (NASDAQ: MDCO) and noted catalysts ahead.MDCO could publish ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE